RELATED ATTORNEYS

Matthew J. Goggin | Alexandra J. Olson

We represented Watson in this Hatch-Waxman patent litigation involving Watson’s ANDA for a generic version of Takeda’s Colcrys® colchicine tablets.  Takeda asserted 17 patents covering several uses of colchicine.  The case is currently stayed pending FTC approval of settlement.  District of Delaware (2014-2015)